About
Pixl Bio develops human iPSC-derived cellular models combined with AI-driven phenomics and automated imaging to generate predictive and reproducible data for drug discovery and safety assessment.
Explore Pixl Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.